Core Laboratories Inc reports results for the quarter ended in September - Earnings Summary

Core Laboratories

01/11/2023 23:09

* Core Laboratories Inc  CLB.N  reported quarterly adjusted
earnings of 22 cents​​ per share for the quarter ended in
September, higher than the same quarter last year, when the
company reported EPS of 18 cents.  The mean expectation of
eight analysts for the quarter was for earnings of 22 cents per
share. Wall Street expected results to range from 18 cents to 24
cents per share.
    * Revenue fell 0.5% to $125.34 million from a year ago;
analysts
expected $129.98 million. 
    * Core Laboratories Inc's reported EPS for the quarter was
19
cents​.
    * The company reported quarterly net income of $9.26
million.
    * Core Laboratories Inc shares had fallen by 10.8% this
quarter and gained 5.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 6
"hold" and 2 "sell" or "strong sell." 
    * The average consensus recommendation for the business
support
services peer group is also "hold"

Wall Street's median 12-month price target for Core Laboratories
Inc is $21.50 
This summary was machine generated from LSEG data November 1 at
11:09 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      0.22           0.22           Met
 Jun. 30 2023      0.20           0.21           Beat
 Mar. 31 2023      0.16           0.19           Beat
 Dec. 31 2022      0.20           0.20           Met